Why Is Protein-Energy Wasting Associated With Mortality in Chronic Kidney Disease?

被引:155
作者
Kovesdy, Csaba P. [1 ,2 ]
Kalantar-Zadeh, Kamyar [3 ,4 ]
机构
[1] Salem Vet Affairs Med Ctr, Div Nephrol, Salem, VA 24153 USA
[2] Univ Virginia, Dept Med, Charlottesville, VA USA
[3] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Nephrol & Hypertens, Harold Simmons Ctr Kidney Dis Res & Epidemiol, Torrance, CA 90509 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
Protein-energy wasting; mortality; chronic kidney disease; muscle wasting; obesity paradox; hypoalbuminemia; BODY-MASS INDEX; C-REACTIVE PROTEIN; NONTRADITIONAL RISK-FACTORS; SHORT DAILY HEMODIALYSIS; DIALYSIS PATIENTS; CARDIOVASCULAR-DISEASE; MAINTENANCE DIALYSIS; PLASMA GELSOLIN; REVERSE EPIDEMIOLOGY; OBESITY PARADOX;
D O I
10.1016/j.semnephrol.2008.10.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Observational studies in chronic kidney disease (CKD) populations consistently have shown the strong mortality-predictability of such markers of protein-energy wasting (PEW) as hypoalbuminemia, low serum cholesterol levels, low body mass index, and reduced dietary protein intake. Even though the PEW-mortality association data traditionally are reported mostly in maintenance dialysis patients, emerging studies extend the existence of these associations to predialysis stages of CKD. Paradoxic risk factor patterns (reverse epidemiology) for both obesity and cholesterol recently have been reported in predialysis CKD, underscoring the overwhelming impact of PEW, a short-term killer, on reversing the long-term effect of conventional cardiovascular risk factors. Multiple pathophysiologic mechanisms have been suggested to explain the link between PEW and mortality in CKD, including derangements in muscle, adipose tissue, and the gastrointestinal, hematopoietic, and immune systems; complications related to deficiencies of multiple micronutrients; and the maladaptive activation of the inflammatory cascade. In addition to well-described pathophysiologic mechanisms involved in the higher mortality seen with PEW, we also discuss the potential role of novel factors such as circulating actin, gelsolin, and proinflammatory high-density lipoprotein. Whether PEW is causally related to adverse outcomes in CKD needs to be verified in randomized controlled trials of nutritional interventions. The initiation of major clinical trials targeting nutritional interventions with the goal of improving survival in CKD offer the promise of extending the survival of this vulnerable patient population. © 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:3 / 14
页数:12
相关论文
共 86 条
  • [1] ALEXANDER JW, 1993, ARCH SURG-CHICAGO, V128, P1242
  • [2] [Anonymous], 2008, Am J Kidney Dis, V51, pS1
  • [3] Argiles J M, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS39, DOI 10.1016/j.ejon.2005.09.006
  • [4] Misleading associations between cholesterol and vascular outcomes in dialysis patients: The need for randomized trials
    Baigent, Colin
    Landray, Martin J.
    Wheeler, David C.
    [J]. SEMINARS IN DIALYSIS, 2007, 20 (06) : 498 - 503
  • [5] Bergström J, 2000, SEMIN DIALYSIS, V13, P163, DOI 10.1046/j.1525-139x.2000.00044.x
  • [6] The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
    Besarab, A
    Bolton, WK
    Browne, JK
    Egrie, JC
    Nissenson, AR
    Okamoto, DM
    Schwab, SJ
    Goodkin, DA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) : 584 - 590
  • [7] Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: A 2-year multicenter, prospective, randomized study
    Cano, Noel J. M.
    Fouque, Denis
    Roth, Hubert
    Aparicio, Michel
    Azar, Raymond
    Canaud, Bernard
    Chauveau, Philippe
    Combe, Christian
    Laville, Maurice
    Leverve, Xavier M.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (09): : 2583 - 2591
  • [8] IMMUNOLOGICAL ABNORMALITIES IN HEMODIALYSIS-PATIENTS - IMPROVEMENT AFTER PYRIDOXINE THERAPY
    CASCIATO, DA
    MCADAM, LP
    KOPPLE, JD
    BLUESTONE, R
    GOLDBERG, LS
    CLEMENTS, PJ
    KNUTSON, DW
    [J]. NEPHRON, 1984, 38 (01): : 9 - 16
  • [9] Secondary immunodeficiencies, including HIV infection
    Chinen, Javier
    Shearer, William T.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S388 - S392
  • [10] Recombinant plasma gelsolin diminishes the acute inflammatory response to hyperoxia in mice
    Christofidou-Solomidou, M
    Scherpereel, A
    Solomides, CC
    Christie, JD
    Stossel, TP
    Goelz, S
    DiNubile, MJ
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2002, 50 (01) : 54 - 60